Dr Mario Guerrieri is a Radiation Oncologist with GenesisCare in Victoria. He has subspecialty interest in GU malignancies particularly focused on the care of men with prostate cancer. He is actively involved in clinical trials in all stages of prostate cancer. He has actively recruited to ENZARAD and DASL-HiCaP, is currently involved in the use of AI in men with intermediate risk grouping prostate cancer via the ASTUTE clinical trial, and is an author on multiple trials run via GenesisCare in Victoria. In addition to his patient centred care, he is the medical director of the Victorian division of GenesisCare and sits on the board of GenesisCare as a Doctor Director.

Dr Andrew Loblaw is a Radiation Oncologist, Clinician Scientist, and dual Professor in the Department of Radiation Oncology and the Institute of Health Policy Management & Evaluation at the University of Toronto. He’s the Site Group Co-Lead for Genitourinary Oncology at Sunnybrook. He received a Bachelor of Science in Physics from the University of British Columbia and his Doctor of Medicine from Queen’s University. He completed his specialty training in Radiation Oncology concurrent with a Masters degree in Clinical Epidemiology to graduate from the Royal College’s Clinician Investigator Program all at the University of Toronto. Dr Loblaw’s clinical practice and research interest focus on improving outcomes for men with prostate cancer and the healthcare system. He has a particularly interest in the design and conduct of clinical trials, the generation and dissemination of evidence-based guidelines and in image-guided radiotherapy. Dr Loblaw is an Ontario Association of Radiation Oncology Clinician Scientist and a Senior Scientist at the Sunnybrook Research Institute. A Fellow of the American Society of Clinical Oncology (FASCO), he was previous Co-Chair of the ASCO’s Genitourinary Advisory Group and remains Co-Chair of the GU group for Cancer Care Ontario’s Program in Evidence-Based Care. He has authored over 325 peer-reviewed papers and has been awarded grant funding of over Cdn$52M.

Dr Farshad Kasraei is a Radiation Oncologist at St Vincent’s and Mater Hospital Sydney with special interest in treatment of genitourinary cancers. He is a Senior lecturer at UNSW and Notre Dame Universities. He completed his specialist training in 2020 at Liverpool and Campbelltown Hospitals with a year of clinical experience at the Canberra Hospital. In 2020 he was awarded 'Best quality research, faculty of radiation oncology' by FRANZCR. He subsequently undertook a clinical/research fellowship at St George Hospital, NSW, focusing on genitourinary and gastrointestinal malignancies with a special interest in brachytherapy and stereotactic techniques.

Spencer Martin is a Radiation Oncology Advanced Trainee working out of Liverpool, Campbelltown and St. Vincent's hospitals in Sydney, Australia. He completed his medical degree at the University of Sydney is 2018 and his prevocational training at Dubbo Base Hospital in regional NSW. Prior to medicine, he completed his undergraduate and master's degrees in physics and spent time working in the Physics and Engineering Department of the Verspeeten Family Cancer Centre (formerly London Regional Cancer Program) in London, Ontario, Canada.

Dr. Niluja Thiru (B.Sc., MBBS, FRANZCR, MPH, PhD) is a Staff Specialist in Radiation Oncology and holds a Conjoint Senior Lecturer position at The University of Sydney. She completed her medical studies at The University of Queensland and speciality training in Australia before undertaking the Windeyer Brachytherapy Fellowship at Mount Vernon Cancer Centre, UK. Following this she completed her PhD with the Translational Radiobiology group at The University of Manchester on hypoxia gene expression signatures in prostate cancer. Her research interests primarily focus on radiation response biomarkers, with a particular emphasis on their application in genitourinary and gynaecological cancers.

George is a senior staff specialist in radiation oncology at RNSH, and a VRO at GenesisCare and Dubbo Base Hospital. His area of interest are GU and GI malignancies. Following a general clinical fellowship at the Royal Prince Alfred Hospital in 1999, he was awarded a post-graduate fellowship at the University of Toronto specializing in GU malignancies and prostate brachytherapy. This fellowship cemented a career long interest and aptitude for research directed clinical work - always striving to combine cutting edge technologies with scientific evidence to improve patient care. George returned to Australia in Dec 2000 commencing as a Staff Specialist in Radiation Oncology at Royal Prince Alfred Hospital. He also established a close working relationship with the urologists in Noumea and has treated many New Caledonians with GU and GI malignancies over the years. Following his return from Toronto, George established the High Dose Rate brachytherapy program at Royal Prince Alfred Hospital performing over 300 implants since its inception in 2002. Other skills honed include trans-perineal biopsies, fiducial marker placement and inserting hydrogel spacer. George was instrumental in introducing more sophisticated techniques for the treatment of prostate cancer patients such as image guided radiation treatment (IGRT) at RPA. In 2014 George treated the first prostate cancer patients with SABR (stereotactic ablative body radiotherapy) for oligo-metastatic disease at RPA. In 2015, George was invited to join the specialised radiation oncology (SRO) team as a staff specialist at Royal North Shore, and as a Visiting Radiation Oncologist (VRO) at Genesis Care where he currently treats patients at St Vincents Clinic and the Health Hub. He enjoys robust collaboration as part of the GU team along with A/Profs Andrew Kneebone and Thomas Eade. This triumvirate has been a very productive and rewarding partnership with areas of interest including focal re-treatment of prostate cancer, “virtual HDR”; real-time imaging and the introduction of state of the art imaging such as PSMA-PET for staging, targeting, mapping and assessing the response to RT in prostate cancer. As well as contributing to local trials including focal SBRT re-treatment; GH has been heavily involved in national and international trials and is an active participant in TROG (and FROGG) and ANZUP where he serves on the scientific advisory committee. GH has authored numerous peer reviewed publications and is involved in teaching, mentoring and lecturing. He loves a glass of wine, a good novel (more so with the former) and getting his skis to snow.

Dr Ee Siang Choong is a Radiation Oncologist at Olivia Newton John Cancer Centre, Austin Health in Melbourne. His sub-speciality interest include genitourinary, thoracic and lower gastrointestinal oncology. Dr Choong is the co-lead in the Victorian MRI LInac Statewide Service, offering treatment in challenging cases using this technology. His research interests culminated in presentations and publications in stereotactic radiotherapy/radiosurgery across various tumour sites. Dr Choong currently servces as a Radiation Oncology co-chair in eviQ, an online resource of evidence-based cancer treatment protocols used widely in Australia and internationally.

Dr George Cosman is a fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR). He completed his training in Radiation Oncology in 2024 and is currently undertaking a fellowship in brachytherapy at St George Hospital in Sydney, Australia.

Dr Eric Wegener is a Radiation Oncologist with a keen interest in genitourinary cancers, currently practicing full-time clinical services, education, research, and governance activities at GenesisCare in Newcastle, NSW. He is also a PhD candidate at the University of Newcastle, with his research focusing on innovative strategies in prostate radiotherapy to enhance treatment efficacy and minimize toxicities. Furthermore, having contributed to the national eviQ prostate SBRT evidence-based guideline, clinical trials, and a member of the RANZCR professional practise committee.